Trophic factors as modulators of motor neuron physiology and survival: Implications for ALS therapy

Frontiers in Cellular Neuroscience

Volumn 8, Issue FEB, 2014, Pages

  Tovar y Romo, Luis B ^a   Ramírez Jarquín, Uri Nimrod ^a   Lazo Gómez, Rafael ^a   Tapia, Ricardo ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amyotrophic lateral sclerosis; Motor neurons; Neurotrophic factors; Spinal cord neurodegeneration; VEGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 9; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH HORMONE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NERVE GROWTH FACTOR; NEUROTROPHIN 3; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN BAD; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA; SOMATOMEDIN C; TAR DNA BINDING PROTEIN; TROPHIC FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BLOOD BRAIN BARRIER; CELL FUNCTION; CELL SURVIVAL; DEGENERATIVE DISEASE; EXCITOTOXICITY; HAPLOTYPE; HUMAN; INTRACELLULAR SIGNALING; META ANALYSIS (TOPIC); MOTONEURON; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVE FIBER; NERVE FUNCTION; NERVOUS SYSTEM DEVELOPMENT; NEUROMUSCULAR SYNAPSE; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD; UPREGULATION;

EID: 84896964187     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2014.00061     Document Type: Review

References (100)

1. ALS CNTF Treatment Study Group. (1996). A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group. Neurology 46, 1244-1249. doi: 10.1212/wnl.46.5.1244
2. Anand, P., Parrett, A., Martin, J., Zeman, S., Foley, P., Swash, M., et al. (1995). Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat. Med. 1, 168-172. doi: 10.1038/nm0295-168
3. Azzouz, M., Ralph, G. S., Storkebaum, E., Walmsley, L. E., Mitrophanous, K. A., Kingsman, S. M., et al. (2004). VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429, 413-417. doi: 10.1038/nature02544
4. Bechade, C., Mallecourt, C., Sedel, F., Vyas, S., and Triller, A. (2002). Motoneuron- derived neurotrophin-3 is a survival factor for PAX2-expressing spinal interneurons. J. Neurosci. 22, 8779-8784.
5. Bedlack, R. S. (2010). Amyotrophic lateral sclerosis: current practice and future treatments. Curr. Opin. Neurol. 23, 524-529. doi: 10.1097/wco. 0b013e32833c7ac2
6. Beauverd, M., Mitchell, J. D., Wokke, J. H., and Borasio, G. D. (2012). Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst. Rev. 11:CD002064. doi: 10.1002/14651858.CD002064.pub3
7. Bendotti, C., Calvaresi, N., Chiveri, L., Prelle, A., Moggio, M., Braga, M., et al. (2001). Early vacuolization and mitochondrial damage in motor neurons of FALS mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J. Neurol. Sci. 191, 25-33 doi: 10.1016/s0022- 510x(01)00627-x
8. Boonman, Z., and Isacson, O. (1999). Apoptosis in neuronal development and transplantation: role of caspases and trophic factors. Exp. Neurol. 156, 1-15. doi: 10.1006/exnr.1999.7056
9. Borasio, G. D., Robberecht, W., Leigh, P. N., Emile, J., Guiloff, R. J., Jerusalem, F., et al. (1998). A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS/IGF-I Study Group. Neurology 51, 583-586. doi: 10.1212/wnl.51.2.583
10. Brockington, A., Wokke, B., Nixon, H., Hartley, J., and Shaw, P. J. (2007). Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis. BMC Med. Genet. 8:23. doi: 10.1186/1471-2350-8-23
11. Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., et al. (1997). ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338. doi: 10.1016/s0896-6273(00)80272-x
12. Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., et al. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321. doi: 10.1126/science.282.5392.1318
13. Casella, G. T., Almeida, V. W., Grumbles, R. M., Liu, Y., and Thomas, C. K. (2010). Neurotrophic factors improve muscle reinnervation from embryonic neurons. Muscle Nerve 42, 788-797. doi: 10.1002/mus.21757
14. Dal Canto, M. C., and Gurney, M. E. (1995). Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676, 25-40. doi: 10.1016/0006-8993(95)00063-V
15. DeChiara, T. M., Vejsada, R., Poueymirou, W. T., Acheson, A., Suri, C., Conover, J. C., et al. (1995). Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 83, 313-322. doi: 10. 1016/0092-8674(95)90172-8
16. Deng, H. X., Zhai, H., Bigio, E. H., Yan, J., Fecto, F., Ajroud, K., et al. (2010). FUS-immunoreactive inclusions are a common feature in sporadic and non- SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 67, 739-748. doi: 10. 1002/ana.22051
17. Devos, D., Moreau, C., Lassalle, P., Perez, T., De Seze, J., Brunaud-Danel, V., et al. (2004). Low levels of the vascular endothelial growth factor in CSF from early ALS patients. Neurology 62, 2127-2129. doi: 10.1212/01.wnl.0000129913. 44351.a3
18. Dewil, M., Dela Cruz, V. F., Van Den Bosch, L., and Robberecht, W. (2007). Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol. Dis. 26, 332-341. doi: 10.1016/j.nbd.2006.12.023
19. Dodge, J. C., Haidet, A. M., Yang, W., Passini, M. A., Hester, M., Clarke, J., et al. (2008). Delivery ofAAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity. Mol. Ther. 16, 1056-1064. doi: 10. 1038/mt.2008.60
20. Dugas, J. C., Mandemakers, W., Rogers, M., Ibrahim, A., Daneman, R., and Barres, B. A. (2008). A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinalmotor neurons. J. Neurosci. 28, 8294-8305. doi: 10.1523/jneurosci. 2010-08.2008
21. Ernfors, P., Lee, K. F., and Jaenisch, R. (1994a). Mice lacking brain-derived neu- rotrophic factor develop with sensory deficits. Nature 368, 147-150. doi: 10. 1038/368147a0
22. Ernfors, P., Lee, K. F., Kucera, J., and Jaenisch, R. (1994b). Lack of neurotrophin- 3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents. Cell 77, 503-512. doi: 10.1016/0092-8674(94)90 213-5
23. Forger, N. G., Prevette, D., Delapeyriere, O., De Bovis, B., Wang, S., Bartlett, P., et al. (2003). Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo. J. Neurosci. 23, 8854-8858.
24. Fryer, H. J., Wolf, D. H., Knox, R. J., Strittmatter, S. M., Pennica, D., O'leary, R. M., et al. (2000). Brain-derived neurotrophic factor induces excitotoxic sensitivityin cultured embryonic rat spinal motor neurons through activation of the phosphatidylinositol 3-kinase pathway. J. Neurochem. 74, 582-595. doi: 10. 1046/j.1471-4159.2000.740582.x
25. Gora-Kupilas, K., and Josko, J. (2005). The neuroprotective function of vascular endothelial growth factor (VEGF). Folia Neuropathol. 43, 31-39.
26. Gordon, P. H. (2013). Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials. Aging Dis. 4, 295-310. doi: 10.14336/ad.2013.0400295
27. Gould, T. W., Yonemura, S., Oppenheim, R. W., Ohmori, S., and Enomoto, H. (2008). The neurotrophic effects of glial cell line-derived neurotrophic factor on spinal motoneurons are restricted to fusimotor subtypes. J. Neurosci. 28, 2131-2146. doi: 10.1523/jneurosci.5185-07.2008
28. Grieshammer, U., Lewandoski, M., Prevette, D., Oppenheim, R. W., and Martin, G. R. (1998). Muscle-specific cell ablation conditional upon Cre-mediated DNA recombination in transgenic mice leads to massive spinal and cranial motoneuronloss. Dev. Biol. 197, 234-247. doi: 10.1006/dbio.1997.8859
29. Gros-Louis, F., Laurent, S., Lopes, A. A., Khoris, J., Meininger, V., Camu, W., et al. (2003). Absence of mutations in the hypoxia response element ofVEGF in ALS. Muscle Nerve 28, 774-775. doi: 10.1002/mus.10498
30. Grundstrom, E., Askmark, H., Lindeberg, J., Nygren, I., Ebendal, T., and Aquilonius, S. M. (1999). Increased expression of glial cell line-derived neu- rotrophic factor mRNA in muscle biopsies from patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 162, 169-173. doi: 10.1016/s0022-510x(98) 00333-5
31. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264, 1772-1775. doi: 10. 1126/science.8209258
32. Haase, G., Dessaud, E., Garces, A., De Bovis, B., Birling, M., Filippi, P., et al. (2002). GDNF acts through PEA3 to regulate cell body positioning and muscle innervation of specific motor neuron pools. Neuron 35, 893-905. doi: 10. 1016/s0896-6273(02)00864-4
33. Hawryluk, G. W., Mothe, A., Wang, J., Wang, S., Tator, C., and Fehlings, M. G. (2012). An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 21, 2222-2238. doi: 10.1089/scd.2011.0596
34. Holasek, S. S., Wengenack, T. M., Kandimalla, K. K., Montano, C., Gregor, D. M., Curran, G. L., et al. (2005). Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice. Brain Res. 1045, 185-198. doi: 10.1016/j.brainres.2005.03.037
35. Hou, S. T., Jiang, S. X., and Smith, R. A. (2008). Permissive and repulsive cues and signalling pathways of axonal outgrowth and regeneration. Int. Rev. Cell Mol. Biol. 267, 125-181. doi: 10.1016/s1937-6448(08)00603-5
36. Ikeda, O., Murakami, M., Ino, H., Yamazaki, M., Nemoto, T., Koda, M., et al. (2001). Acute up-regulation of brain-derived neurotrophic factor expression resulting from experimentally induced injury in the rat spinal cord. Acta Neuropathol. 102, 239-245.
37. Jones, K. R., Farinas, I., Backus, C., and Reichardt, L. F. (1994). Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development. Cell 76, 989-999. doi: 10.1016/0092- 8674(94)90377-8
38. Kablar, B., and Rudnicki, M. A. (1999). Development in the absence of skeletal muscle results in the sequential ablation of motor neurons from the spinal cord to the brain. Dev. Biol. 208, 93-109. doi: 10.1006/dbio.1998.9184
39. Kaspar, B. K., Llado, J., Sherkat, N., Rothstein, J. D., and Gage, F. H. (2003). Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 301, 839-842. doi: 10.1126/science.1086137
40. Kilic, U., Kilic, E., Jarve, A., Guo, Z., Spudich, A., Bieber, K., et al. (2006). Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways. J. Neurosci. 26, 12439-12446. doi: 10.1523/jneurosci.0434-06.2006
41. Kim, S. H., Won, S. J., Sohn, S., Kwon, H. J., Lee, J. Y., Park, J. H., et al. (2002). Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation ofNADPH oxidase. J. Cell Biol. 159, 821-831. doi: 10.1083/jcb.200112131
42. Koh, S. H., Roh, H., Lee, S. M., Kim, H. J., Kim, M., Lee, K. W., et al. (2005). Phos- phatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene. Toxicology 213, 45-55. doi: 10.1016/j.tox.2005.05.009
43. Korsching, S. (1993). The neurotrophicfactor concept:areexamination. J. Neurosci. 13, 2739-2748.
44. Kotzbauer, P. T., and Holtzman, D. M. (2006). Expectations and challenges in the therapeutic use of neurotrophic factors. Ann. Neurol. 59, 444-447. doi: 10. 1002/ana.20794
45. Krakora, D., Mulcrone, P., Meyer, M., Lewis, C., Bernau, K., Gowing, G., et al. (2013). Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial als rat model. Mol. Ther. 21, 1602-1610. doi: 10.1038/mt. 2013.108
46. Kramer, E. R., Knott, L., Su, F., Dessaud, E., Krull, C. E., Helmbacher, F., et al. (2006). Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor- axon pathway selection in the limb. Neuron 50, 35-47. doi: 10.1016/j.neuron. 2006.02.020
47. Laaksovirta, H., Soinila, S., Hukkanen, V., Roytta, M., and Soilu-Hanninen, M. (2008). Serum level of CNTF is elevated in patients with amyotrophic lateral sclerosis and correlates with site of disease onset. Eur. J. Neurol. 15, 355-359. doi: 10.1111/j.1468-1331.2008.02080.x
48. Lai, E. C., Felice, K. J., Festoff, B. W., Gawel, M. J., Gelinas, D. F., Kratz, R., et al. (1997). Effect of recombinant human insulin-like growth factor-I on progression ofALS. A placebo-controlled study. The North America ALS/IGF-I Study Group. Neurology 49, 1621-1630. doi: 10.1212/wnl.49.6.1621
49. Lambrechts, D., Poesen, K., Fernandez-Santiago, R., Al-Chalabi, A., Del Bo, R., Van Vught, P. W., et al. (2009). Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J. Med. Genet. 46, 840-846. doi: 10.1136/jmg. 2008.058222
50. Leitner, M. L., Molliver, D. C., Osborne, P. A., Vejsada, R., Golden, J. P., Lampe, P. A., et al. (1999). Analysis of the retrograde transport of glial cell line-derived neurotrophic factor (GDNF), neurturin, and persephin suggests that in vivo signaling for the GDNF family is GFRalpha coreceptor-specific. J. Neurosci. 19, 9322-9331.
51. Li, B., Xu, W., Luo, C., Gozal, D., and Liu, R. (2003). VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res. Mol. Brain Res. 111, 155-164. doi: 10.1016/s0169- 328x(03)00025-1
52. Liao, B., Zhao, W., Beers, D. R., Henkel, J. S., and Appel, S. H. (2012). Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model ofALS. Exp. Neurol. 237, 147-152. doi: 10.1016/j.expneurol.2012. 06.011
53. Lunetta, C., Serafini, M., Prelle, A., Magni, P., Dozio, E., Ruscica, M., et al. (2012). Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve 45, 200-208. doi: 10. 1002/mus.22288
54. Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., and Thoenen, H. (1993). Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27-32. doi: 10.1038/365027a0
55. Matsuzaki, H., Tamatani, M., Yamaguchi, A., Namikawa, K., Kiyama, H., Vitek, M. P., et al. (2001). Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 15, 1218-1220. doi: 10.1096/fj.00-0495fje
56. Mitsumoto, H., Ikeda, K., Holmlund, T., Greene, T., Cedarbaum, J. M., Wong, V., et al. (1994). The effects of ciliary neurotrophic factor on motor dysfunction in wobbler mouse motor neuron disease. Ann. Neurol. 36, 142-148. doi: 10. 1002/ana.410360205
57. Mohajeri, M. H., Figlewicz, D. A., and Bohn, M. C. (1999). Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis. Hum. Gene Ther. 10, 1853-1866. doi: 10. 1089/10430349950017536
58. Moreau, C., Gosset, P., Kluza, J., Brunaud-Danel, V., Lassalle, P., Marchetti, P., et al. (2011). Deregulation of the hypoxia inducible factor-1alpha pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience 172, 110-117. doi: 10.1016/j.neuroscience.2010.10.040
59. Morrison, B. M., Janssen, W. G., Gordon, J. W., and Morrison, J. H. (1998). Time course of neuropathology in the spinal cord of G86R superoxide dis- mutase transgenic mice. J. Comp. Neurol. 391, 64-77. doi: 10.1002/(sici)1096- 9861(19980202)391:1<64::aid-cne6>3.0.co;2-p
60. Morselli, L. L., Bongioanni, P., Genovesi, M., Licitra, R., Rossi, B., Murri, L., et al. (2006). Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clin. Endocrinol. (Oxf) 65, 385-388. doi: 10.1111/j.1365-2265.2006.02609.x
61. Mudò, G., Bonomo, A., Di Liberto, V., Frinchi, M., Fuxe, K., and Belluardo, N. (2009). The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J. Neural Transm. 116, 995-1005. doi: 10.1007/s00702-009-0207-z
62. Nagano, I., Shiote, M., Murakami, T., Kamada, H., Hamakawa, Y., Matsubara, E., et al. (2005). Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol. Res. 27, 768-772. doi: 10. 1179/016164105x39860
63. Nagara, Y., Tateishi, T., Yamasaki, R., Hayashi, S., Kawamura, M., Kikuchi, H., et al. (2013). Impaired cytoplasmic-nuclear transport of hypoxia-inducible factor- 1alpha in amyotrophic lateral sclerosis. Brain Pathol. 23, 534-546. doi: 10. 1111/bpa.12040
64. Namikawa, K., Honma, M., Abe, K., Takeda, M., Mansur, K., Obata, T., et al. (2000). Akt/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J. Neurosci. 20, 2875-2886.
65. Nguyen, Q. T., Parsadanian, A. S., Snider, W. D., and Lichtman, J. W. (1998). Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279, 1725-1729. doi: 10.1126/science.279.5357.1725
66. Oosthuyse, B., Moons, L., Storkebaum, E., Beck, H., Nuyens, D., Brusselmans, K., et al. (2001). Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28, 131-138. doi: 10.1038/88842
67. Oppenheim, R. W. (1991). Cell death during development of the nervous system. Annu. Rev. Neurosci. 14, 453-501. doi: 10.1146/annurev.neuro.14.1.453
68. Oppenheim, R. W., Haverkamp, L. J., Prevette, D., Mcmanaman, J. L., and Appel, S. H. (1988). Reduction of naturally occurring motoneuron death in vivo by a target-derived neurotrophic factor. Science 240, 919-922. doi: 10.1126/science. 3363373
69. Oppenheim, R. W., Wiese, S., Prevette, D., Armanini, M., Wang, S., Houenou, L. J., et al. (2001). Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J. Neurosci. 21, 1283-1291.
70. Raoul, C., Buhler, E., Sadeghi, C., Jacquier, A., Aebischer, P., Pettmann, B., et al. (2006). Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL. Proc. Natl. Acad. Sci. USA 103, 6007-6012. doi: 10.1073/pnas.0508774103
71. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62. doi: 10.1038/ 362059a0
72. Saccà, F., Quarantelli, M., Rinaldi, C., Tucci, T., Piro, R., Perrotta, G., et al. (2012). A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. J. Neurol. 259, 132-138. doi: 10.1007/s00415-011-6146-2
73. Sato, K., Morimoto, N., Kurata, T., Mimoto, T., Miyazaki, K., Ikeda, Y., et al. (2012). Impaired response of hypoxic sensor protein HIF-1alpha and its downstream proteins in the spinal motor neurons of ALS model mice. Brain Res. 1473, 55-62. doi: 10.1016/j.brainres.2012.07.040
74. Sendtner, M., Schmalbruch, H., Stockli, K. A., Carroll, P., Kreutzberg, G. W., and Thoenen, H. (1992). Ciliaryneurotrophicfactor prevents degeneration ofmotor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502-504. doi: 10.1038/358502a0
75. Shook, S. J., and Pioro, E. P. (2009). Racing against the clock: recognizing, differentiating, diagnosing and referring the amyotrophic lateral sclerosis patient. Ann. Neurol. 65(Suppl. 1), S10-S16. doi: 10.1002/ana.21545
76. Siciliano, G., Carlesi, C., Pasquali, L., Piazza, S., Pietracupa, S., Fornai, F., et al. (2010). Clinical trials for neuroprotection in ALS. CNS Neurol. Disord. Drug Targets 9, 305-313. doi: 10.2174/187152710791292648
77. Sreedharan, J., and Brown, R. H. Jr. (2013). Amyotrophic lateral sclerosis: problems and prospects. Ann. Neurol. 74, 309-316. doi: 10.1002/ana.24012
78. Stephens, B., Guiloff, R. J., Navarrete, R., Newman, P., Nikhar, N., and Lewis, P. (2006). Widespread loss of neuronal populations in the spinal ventral horn in sporadic motor neuron disease. A morphometric study. J. Neurol. Sci. 244, 41-58. doi: 10.1016/j.jns.2005.12.003
79. Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M. P., Appelmans, S., Oh, H., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8, 85-92. doi: 10.1038/nn1360
80. Su, H., Zhang, W., Guo, J., Guo, A., Yuan, Q., and Wu, W. (2009). Neural progenitor cells enhance the survival and axonal regeneration of injured motoneurons after transplantation into the avulsed ventral horn of adult rats. J. Neurotrauma 26, 67-80. doi: 10.1089/neu.2008.0656
81. Suzuki, M., and Svendsen, C. N. (2008). Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci. 31, 192-198. doi: 10. 1016/j.tins.2008.01.006
82. Suzuki, M., Mchugh, J., Tork, C., Shelley, B., Hayes, A., Bellantuono, I., et al. (2008). Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol. Ther. 16, 2002-2010. doi: 10.1038/mt.2008.197
83. Suzuki, M., Mchugh, J., Tork, C., Shelley, B., Klein, S. M., Aebischer, P., et al. (2007). GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One 2:e689. doi: 10.1371/journal.pone.0000689
84. The BDNF Study Group. (1999). A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF study group (phase III). Neurology 52, 1427-1433. doi: 10.1212/WNL.52.7.1427
85. Tokumine, J., Sugahara, K., Kakinohana, O., and Marsala, M. (2003). The spinal GDNF level is increased after transient spinal cord ischemia in the rat. Acta Neurochir. Suppl. 86, 231-234. doi: 10.1007/978-3-7091-0651-8_50
86. Tolosa, L., Mir, M., Asensio, V. J., Olmos, G., and Llado, J. (2008). Vascular endothelial growth factor protects spinal cord motoneurons against glutamate- induced excitotoxicity via phosphatidylinositol 3-kinase. J. Neurochem. 105, 1080-1090. doi: 10.1111/j.1471-4159.2007.05206.x
87. Tolosa, L., Mir, M., Olmos, G., and Llado, J. (2009). Vascular endothelial growth factor protects motoneurons from serum deprivation-induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition. Neuroscience 158, 1348-1355. doi: 10.1016/j.neuroscience. 2008.10.060
88. Tortarolo, M., Veglianese, P., Calvaresi, N., Botturi, A., Rossi, C., Giorgini, A., et al. (2003). Persistent activation of p38 mitogen-activated protein kinase inamouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol. Cell. Neurosci. 23, 180-192. doi: 10.1016/s1044-7431(03)00022-8
89. Tovar-Y-Romo, L. B., and Tapia, R. (2010). VEGF protects spinal motor neurons against chronic excitotoxic degeneration in vivo byactivation ofPI3-K pathway and inhibition of p38MAPK. J. Neurochem. 115, 1090-1101. doi: 10.1111/j. 1471-4159.2010.06766.x
90. Tovar-Y-Romo, L. B., and Tapia, R. (2012). Delayed administration ofVEGF rescues spinal motor neurons from death with a short effective time frame in excito- toxic experimental models in vivo. ASNNeuro 4, 121-129. doi: 10.1042/an201 10057
91. Tovar-Y-Romo, L. B., Zepeda, A., and Tapia, R. (2007). Vascular endothelial growth factor prevents paralysis and motoneuron death in a rat model of excitotoxic spinal cord neurodegeneration. J. Neuropathol. Exp. Neurol. 66, 913-922. doi: 10. 1097/nen.0b013e3181567c16
92. Veglianese, P., Lo Coco, D., Bao Cutrona, M., Magnoni, R., Pennacchini, D., Pozzi, B., et al. (2006). Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol. Cell. Neurosci. 31, 218-231. doi: 10.1016/j.mcn.2005.09.009
93. Vicario-Abejon, C., Fernandez-Moreno, C., Pichel, J. G., and De Pablo, F. (2004). Mice lacking IGF-I and LIF have motoneuron deficits in brain stem nuclei. Neuroreport 15, 2769-2772.
94. Wang, L. J., Lu, Y. Y., Muramatsu, S., Ikeguchi, K., Fujimoto, K., Okada, T., et al. (2002). Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22, 6920-6928.
95. Wang, Y., Mao, X. O., Xie, L., Banwait, S., Marti, H. H., Greenberg, D. A., et al. (2007). Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J. Neurosci. 27, 304-307. doi: 10.1523/jneurosci.4433-06.2007
96. Wu, D. C., Re, D. B., Nagai, M., Ischiropoulos, H., and Przedborski, S. (2006). The inflammatory NADPH oxidase enzyme modulates motor neuron degeneration in amyotrophic lateral sclerosis mice. Proc. Natl. Acad. Sci. U S A 103, 12132-12137. doi: 10.1073/pnas.0603670103
97. Yanpallewar, S. U., Barrick, C. A., Buckley, H., Becker, J., and Tessarollo, L. (2012). Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One 7:e39946. doi: 10. 1371/journal.pone.0039946
98. Yu, F., Sugawara, T., Maier, C. M., Hsieh, L. B., and Chan, P. H. (2005). Akt/Bad signaling and motor neuron survival after spinal cord injury. Neurobiol. Dis. 20, 491-499. doi: 10.1016/j.nbd.2005.04.004
99. Zachary, I. (2005). Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function and therapeutic potential. Neurosignals 14, 207-221. doi: 10.1159/000088637
100. Zheng, C., Nennesmo, I., Fadeel, B., and Henter, J. I. (2004). Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 56, 564-567. doi: 10.1002/ana.20223